Latest News

Scientists ID compounds that target amyloid fibrils in Alzheimer's, other brain diseases

Scientists report an advance toward "structure-based drug design," with the potential to delay or treat Alzheimer's disease, Parkinson's disease, type II diabetes, ALS (also known as Lou Gehrig's disease) and many other degenerative diseases.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • No 'bird brains'? Crows exhibit advanced relational thinking, study suggests

  • In one aspect of vision, computers catch up to primate brain

  • A clear, molecular view of how human color vision evolved

  • A Facebook application knows if you are having a bad day and tells your teacher

  • Personalized advertising attracts more attention and makes contents of ads easier to remember

  • Lost memories might be able to be restored, suggests research into marine snail

  • Family criticizing your weight? You might add more pounds

  • Early exposure to antidepressants affects adult anxiety, serotonin transmission

  • Cocaine, amphetamine users more likely to take their own lives

  • New technology advances eye tracking as biomarker for brain function, recovery from brain injury

  •